First human test of new drug ARGX-109 completed
NCT ID NCT06799416
Summary
This was an early safety study to see if a new drug called ARGX-109 is safe for people and how it moves through the body. It involved 40 healthy adults who received a single injection. The main goal was to check for side effects and measure drug levels in the blood over about 20 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences - Montreal - Phase I unit
Mount Royal, Quebec, H3P 3P1, Canada
Conditions
Explore the condition pages connected to this study.